BioNTech: Perbedaan antara revisi

"Project Lightspeed", adalah proyek pengembangan teknologi mRNA baru untuk vaksin COVID-19 yang dimulai pada pertengahan bulan Januari 2020, hanya beberapa hari setelah [[urutan asam nukleat]] [[SARS-Cov-2]] pertama kali dipublikasikan.<ref>{{cite web|url=https://biontech.de/covid-19|title=Aiming to address the global coronavirus pandemic: Project Lightspeed|publisher=BioNTech|year=2020|access-date=13 December 2020}}</ref> Untuk proyek ini, BioNTech bermitra dengan [[Pfizer]]<ref>{{cite news |last=Lovelace Jr. |first=Berkeley |date=27 July 2020 |title=Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday |url=https://www.cnbc.com/2020/07/27/pfizer-and-biontech-began-late-stage-human-trial-for-coronavirus-vaccine-monday.html |publisher=[[CNBC]] |access-date=2 August 2020}}</ref> dan [[Fosun International|Fosun]].<ref>{{cite news |author=<!--Not stated.--> |title=BioNTech in China alliance with Fosun over coronavirus vaccine candidate |url=https://www.reuters.com/article/biontech-fosunpharma-vaccine-collaborati/biontech-in-china-alliance-with-fosun-over-coronavirus-vaccine-candidate-idUSL8N2B90UW |work=[[Reuters]] |location=Frankfurt |date=15 March 2020 |access-date=2 August 2020}}</ref><ref>{{cite news |last=Burger |first=Ludwig |title=Germany approves trials of COVID-19 vaccine candidate |url=https://www.reuters.com/article/us-health-coronavirus-vaccine-biontech/germany-approves-trials-of-covid-19-vaccine-candidate-idUSKCN2241DN |work=[[Reuters]] |location=Berlin |date=22 April 2020 |access-date=2 August 2020}}</ref>

 

 

== Referensi ==